
News|Articles|November 4, 2022
Daily Dose: Weight Loss Management in Primary Care
Author(s)Sydney Jennings
Your daily dose of clinical news you may have missed.
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On November 3, 2022, we reviewed a study presented at ObesityWeek® 2022, that examined current weight management services provided in primary care practice and factors associated with a higher reported provision of services.
The study
Researchers surveyed primary care clinicians in 18 health system practices throughout Colorado to assess the amount and type of weight loss assistance offered to patients. Clinicians were presented with a list of 19 weight management services, eg, identifying obesity, educating patients, prescribing medications.
Of the 397 surveys, investigators received 257 for a response rate of 65%. On average, clinicians reported performing 70% of the services listed. When the services were grouped into minimal, basic, and extensive types, clinicians on average performed 87%, 78%, and 69% of them, respectively.
Clinical implications
“Practice-associated factors such as culture and implementation climate may be worth examining to understanding how to implement weight management in primary care. These data add to the growing knowledge base about overcoming challenges to address obesity in the US.”
Click here for the full study review.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Semaglutide CV Effects Appear Independent of Baseline Adiposity, Suggesting Disease-Modifying Potential
2
Elinzanetant Improves Sleep Through VMS-Independent Mechanisms, According to New Pooled Analysis
3
Topline Real-World Data Show Fezolinetant Improves VMS, Sleep, and Work Productivity in Women With Confirmed Menopausal VMS
4
APOE ε4 and Inflammation Amplify Risk for Memory Decline in Women with Earlier Menopause
5